84-2155-93 sTNFR2 (Tumor Necrosis Factor Receptor Superfamily Member 1B, Tumor Necrosis Factor Receptor 2, TNF-R2, Tumor Necrosis Factor Receptor Type II, TNF-RII, TNFR-II, p75, p80 TNF-alpha Receptor, CD120b, Etanercept, TNFRSF1B, TNFBR) (HRP) 100ul 143677-HRP

※お見積書はカートで印刷できます

冷凍

特徴

  • TNF RII (p75, CD120b) is a 75kD transmembrane glycoprotein originally isolated from a human lung fibroblast library.
  • Among the multitude of cells known to express TNFRII are monocytes, endothelial cells, Langerhans cells, and macrophages.
  • Mouse to human amino acid sequence identity in the TNFRII cytoplasmic domain is 73%, while aa sequence identity in the extracellular region falls to 58%.
  • This drop in extracellular identity is reflected in the observation that human TNF-alpha is not active in the mouse system.
  • TNF RII to TNF RI, amino acid sequence identity is only about 20% in the extracellular region and 5% in the cytoplasmic domain.
  • TNF RII consists of a 240aa residue extracellular region, a 27aa residue transmembrane segment and a 173aa residue cytoplasmic domain.
  • TNF R1 and TNF R2 are members of a family of structurally related membrane receptors that includes lymphotoxin receptor, Fas, WSL1, DR4, CD40, CD30, CD27, 4-1BB, OX40, and p75 nerve growth factor receptor.
  • Members of the TNFR family can interact through their cytoplasmic domains with a range of intracellular signalling proteins, most of which fall into two distinct groups.
  • The first is the death domain containing proteins, including TRADD, FADD/MORT1, and RIP, which associate directly with receptors also containing death domains, such as TNF R1 and Fas.
  • The second is the TRAF proteins.
  • TRAF1 and TRAF2 were originally identified by their association with the cytoplasmic domain of TNFR2.
  • TRAF proteins appear to function as adaptor proteins.
  • TRAF2 directly binds at least eight intracellular molecules, including TRAF1, cIAP1, cIAP2, I-TRAF/TANK, A20, TRIP, RIP, and NIK.
  • The best characterized TRAFmediated signal transduction pathway is the activation of NF-B transcription factors.
  • TRAF2 mediates NF-B activation via the recruitment of the serine/threonine kinase NIK, which can in turn activate CHUK, an IBspecific kinase that triggers IB degradation.
  • In addition to recruiting mediators of NF-B activation, TRAF2 can bind at least three other molecules (I-TRAF/TANK, A20, TRIP) that inhibit its ability to activate NF-B.
  • Applications:Suitable for use in ELISA, Western Blot, Immunohistochemistry and Neutralization.
  • Other applications not tested.
  • Recommended Dilution:ELISA: To detect hsTNF-receptor II by sandwich ELISA (using 100ul/well antibody solution) a concentration of 0.5-2ug/ml of this antibody is required.
  • This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human sTNF-receptor II as a detection antibody, allows the detection of at least 0.2-0.4ng/well of recombinant hsTNF-receptor II
  • Western Blot: To detect hsTNF-receptor II by Western Blot analysis this antibody can be used at a concentration of 0.1- 0.2ug/ml.
  • Used in conjunction with compatible secondary reagents the detection limit for recombinant hsTNF-receptor II is 1.5-3ng/lane, under either reducing or non-reducing conditions
  • Immunohistochemistry: This antibody stained PC-3 and CaCo-2 cells.; The primary antibody was incubated at 3mg/ml overnight at 4°C followed by a fluorescent labeled secondary antibody
  • Neutralization: To yield one-half maximal inhibition of the biological activity of Human sTNF Receptor-II (0.5ug/ml) a concentration of 15-20ug/ml of this antibody is required
  • Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Store product at 4°C if to be used immediately within two weeks.
  • For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20°C.
  • Aliquots are stable at -20°C for 12 months after receipt.
  • Dilute required amount only prior to immediate use.
  • Further dilutions can be made in assay buffer.
  • Note: Sodium azide is a potent inhibitor of peroxidase and should not be added to HRP conjugates.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Note: Applications are based on unconjugated antibody.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Immunoaffinity chromatography.
  • Form:Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with horseradish peroxidase (HRP).
  • Specificity:Recognizes human sTNF Receptor Type II.
  • Isotype:IgG
  • Calc Applications Abbrev:E IHC N WB
  • Calc Crossreactivity:Hu
  • Immunogen:Recombinant protein corresponding to human sTNF Receptor Type II, expressed in E. coli.
  • Shelf Life:1year
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-2155-93
型番
143677-HRP
入り数
1個
標準価格
251,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る